Literature DB >> 15511015

Epidemiological studies of UK test veterans: II. Mortality and cancer incidence.

C R Muirhead1, G M Kendall, S C Darby, R Doll, R G E Haylock, J A O'Hagan, G L C Berridge, M A Phillipson, N Hunter.   

Abstract

An epidemiological study was set up in the 1980s of UK participants in the UK atmospheric nuclear weapons testing programme. A large cohort of test participants was established along with a closely matched comparison or control group. Three analyses of mortality and cancer incidence have been carried out. This review describes the development of the evidence on possible effects on test participants with especial emphasis on the most recent analysis. Other sources of evidence, particularly from studies of other groups of test participants, are also considered. It was concluded that overall levels of mortality and cancer incidence in UK nuclear weapons test participants were similar to those in a matched control group, and overall mortality was lower than expected from national rates. There was no evidence of an increased raised risk of multiple myeloma among test participants in recent years, and the suggestion in the first analysis of this cohort of a raised myeloma risk relative to controls is likely to have been a chance finding. There was some evidence of a raised risk of leukaemia other than chronic lymphatic leukaemia among test participants relative to controls, particularly in the early years after the tests. Whilst this could be a chance finding, the possibility that test participation caused a small absolute risk of leukaemia other than chronic lymphatic leukaemia cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15511015     DOI: 10.1088/0952-4746/24/3/002

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  6 in total

1.  Mortality among military participants at the 1957 PLUMBBOB nuclear weapons test series and from leukemia among participants at the SMOKY test.

Authors:  Glyn G Caldwell; Matthew M Zack; Michael T Mumma; Henry Falk; Clark W Heath; John E Till; Heidi Chen; John D Boice
Journal:  J Radiol Prot       Date:  2016-06-29       Impact factor: 1.394

2.  Military participants at U.S. Atmospheric nuclear weapons testing--methodology for estimating dose and uncertainty.

Authors:  John E Till; Harold L Beck; Jill W Aanenson; Helen A Grogan; H Justin Mohler; S Shawn Mohler; Paul G Voillequé
Journal:  Radiat Res       Date:  2014-04-23       Impact factor: 2.841

Review 3.  Ionizing Radiation Exposure and Basal Cell Carcinoma Pathogenesis.

Authors:  Changzhao Li; Mohammad Athar
Journal:  Radiat Res       Date:  2016-03-01       Impact factor: 2.841

Review 4.  Health Impacts of Low-Dose Ionizing Radiation: Current Scientific Debates and Regulatory Issues.

Authors:  Alexander Vaiserman; Alexander Koliada; Oksana Zabuga; Yehoshua Socol
Journal:  Dose Response       Date:  2018-09-19       Impact factor: 2.658

5.  Exposure Worry: The Psychological Impact of Perceived Ionizing Radiation Exposure in British Nuclear Test Veterans.

Authors:  George Collett; William R Young; Wendy Martin; Rhona M Anderson
Journal:  Int J Environ Res Public Health       Date:  2021-11-20       Impact factor: 3.390

Review 6.  Can Peto's paradox be used as the null hypothesis to identify the role of evolution in natural resistance to cancer? A critical review.

Authors:  Hugo Ducasse; Beata Ujvari; Eric Solary; Marion Vittecoq; Audrey Arnal; Florence Bernex; Nelly Pirot; Dorothée Misse; François Bonhomme; François Renaud; Frédéric Thomas; Benjamin Roche
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.